Science 2.0: Sharing and Collaboration

The New Science of Sharing. ‘Companies such as Novartis and Intel are at the forefront of Science 2.0 by encouraging open systems of collaboration. Earlier this month, Swiss drugmaker Novartis did something rather unusual—and almost unheard of in the high-stakes, highly competitive world of Big Pharma. After investing millions trying to unlock the genetic basis of type 2 diabetes, the company released all of its raw data on the Internet. This means anyone (or any company) with the inclination is free to use the data—no strings attached. In other words, the research conducted by Novartis and its university partners at MIT and Lund University in Sweden merely sets the stage for the more complex and costly drug identification and development process. According to researchers, there are far more leads than any one lab could possibly follow up alone. So by placing its data in the public domain, Novartis hopes to leverage the talents and insights of a global research community to dramatically scale and speed up its early-stage R&D activities.’



Speak Your Mind

*